168 related articles for article (PubMed ID: 32831094)
1. HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service.
Torres-Leguizamon M; Reynaud EG; Néfau T; Duplessy C
Harm Reduct J; 2020 Aug; 17(1):59. PubMed ID: 32831094
[TBL] [Abstract][Full Text] [Related]
2. Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA.
Torres-Leguizamon M; Favaro J; Coello D; Reynaud EG; Néfau T; Duplessy C
Harm Reduct J; 2023 Jan; 20(1):1. PubMed ID: 36611167
[TBL] [Abstract][Full Text] [Related]
3. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
[TBL] [Abstract][Full Text] [Related]
4. Practices of care among people who buy, use, and sell drugs in community settings.
Kolla G; Strike C
Harm Reduct J; 2020 May; 17(1):27. PubMed ID: 32381011
[TBL] [Abstract][Full Text] [Related]
5. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
[TBL] [Abstract][Full Text] [Related]
6. Harm reduction via online platforms for people who use drugs in Russia: A qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Res Sq; 2020 Sep; ():. PubMed ID: 32995761
[TBL] [Abstract][Full Text] [Related]
7. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.
Russell C; Ali F; Nafeh F; LeBlanc S; Imtiaz S; Elton-Marshall T; Rehm J
BMC Public Health; 2021 Nov; 21(1):2021. PubMed ID: 34742267
[TBL] [Abstract][Full Text] [Related]
8. Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.
Wiessing L; Ferri M; Běláčková V; Carrieri P; Friedman SR; Folch C; Dolan K; Galvin B; Vickerman P; Lazarus JV; Mravčík V; Kretzschmar M; Sypsa V; Sarasa-Renedo A; Uusküla A; Paraskevis D; Mendão L; Rossi D; van Gelder N; Mitcheson L; Paoli L; Gomez CD; Milhet M; Dascalu N; Knight J; Hay G; Kalamara E; Simon R; ; Comiskey C; Rossi C; Griffiths P
Harm Reduct J; 2017 Apr; 14(1):19. PubMed ID: 28431584
[TBL] [Abstract][Full Text] [Related]
9. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
[TBL] [Abstract][Full Text] [Related]
10. People who use drugs engagement in substance use disorder services and harm reduction: evaluation, challenges and future direction of a community-based intervention.
Gleason-Comstock J; Calhoun CB; Locke BJ; Boorle NVLD; Cobty K; McKenney T; Uddin KO; Bauer SJ; Xu J
Subst Abuse Treat Prev Policy; 2024 Apr; 19(1):24. PubMed ID: 38689339
[TBL] [Abstract][Full Text] [Related]
11. Harm Reduction Services in Ottawa: The Culture of Drug Use.
Haines M; O'Byrne P
Res Theory Nurs Pract; 2020 May; 34(2):188-202. PubMed ID: 32457123
[TBL] [Abstract][Full Text] [Related]
12. Lessons learned from the Amsterdam Cohort Studies among people who use drugs: a historical perspective.
van Santen DK; Coutinho RA; van den Hoek A; van Brussel G; Buster M; Prins M
Harm Reduct J; 2021 Jan; 18(1):2. PubMed ID: 33407562
[TBL] [Abstract][Full Text] [Related]
13. Assessment of health services for people who use drugs in Central Asia: findings of a quantitative survey in Kazakhstan and Kyrgyzstan.
Rosenkranz M; Kerimi N; Takenova M; Impinen A; Mamyrov M; Degkwitz P; Zurhold H; Martens MS
Harm Reduct J; 2016 Jan; 13():3. PubMed ID: 26817827
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
[TBL] [Abstract][Full Text] [Related]
16. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL
Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409
[TBL] [Abstract][Full Text] [Related]
17. Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks.
Calvo M; MacFarlane J; Zaccaro H; Curtis M; Cabán M; Favaro J; Passannante MR; Frost T
Drug Alcohol Depend; 2017 Sep; 178():106-114. PubMed ID: 28645060
[TBL] [Abstract][Full Text] [Related]
18. Harm reduction in practice - The Community Oriented Substance Use Programme in Tshwane.
Scheibe A; Shelly S; Hugo J; Mohale M; Lalla S; Renkin W; Gloeck N; Khambule S; Kroukamp L; Bhoora U; Marcus TS
Afr J Prim Health Care Fam Med; 2020 May; 12(1):e1-e6. PubMed ID: 32501031
[TBL] [Abstract][Full Text] [Related]
19. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone.
Perri M; Kaminski N; Bonn M; Kolla G; Guta A; Bayoumi AM; Challacombe L; Gagnon M; Touesnard N; McDougall P; Strike C
Harm Reduct J; 2021 Aug; 18(1):85. PubMed ID: 34353323
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
